Sign inGet started

Bisgaard Peter

Insider CIK 1606387 · RARX Director · EAR Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-22261,701— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-223,738— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-221,330,361— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-2211,086— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-22849,858— $00SEC↗
EAR Eargo, Inc. C Conversion deriv2020-10-202020-10-2224,907— $00SEC↗
EAR Eargo, Inc. C Conversion2020-10-202020-10-222,664,502— $02,664,502SEC↗
EAR Eargo, Inc. P Buy2020-10-202020-10-22222,222$18.00 $4.00M2,886,724SEC↗
EAR Eargo, Inc. C Conversion2020-10-202020-10-2241,969— $041,969SEC↗
EAR Eargo, Inc. A Award deriv2020-10-152020-10-196,666— $06,666SEC↗
RARX Ra Pharmaceuticals, Inc. A Award deriv2018-06-282018-07-0215,000— $015,000SEC↗
RARX Ra Pharmaceuticals, Inc. A Award deriv2017-10-262017-10-3015,000— $015,000SEC↗